Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We sought to determine whether an oral disposition index (DI(O)) predicts the development of diabetes over a 10-year period. First, we assessed the validity of the DI(O) by demonstrating that a hyperbolic relationship exists between oral indexes of insulin sensitivity and beta-cell function. RESEARCH DESIGN AND METHODS: A total of 613 Japanese-American subjects (322 men and 291 women) underwent a 75-g oral glucose tolerance test (OGTT) at baseline, 5 years, and 10 years. Insulin sensitivity was estimated as 1/fasting insulin or homeostasis model assessment of insulin sensitivity (HOMA-S). Insulin response was estimated as the change in insulin divided by change in glucose from 0 to 30 min (DeltaI(0-30)/DeltaG(0-30)). RESULTS: DeltaI(0-30)/DeltaG(0-30) demonstrated a curvilinear relationship with 1/fasting insulin and HOMA-S with a left and downward shift as glucose tolerance deteriorated. The confidence limits for the slope of the log(e)-transformed estimates included -1 for DeltaI(0-30)/DeltaG(0-30) versus 1/fasting insulin for all glucose tolerance groups, consistent with a hyperbolic relationship. When HOMA-S was used as the insulin sensitivity measure, the confidence limits for the slope included -1 only for subjects with normal glucose tolerance (NGT) or impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) but not diabetes. On the basis of this hyperbolic relationship, the product of DeltaI(0-30)/DeltaG(0-30) and 1/fasting insulin was calculated (DI(O)) and decreased from NGT to IFG/IGT to diabetes (P < 0.001). Among nondiabetic subjects at baseline, baseline DI(O) predicted cumulative diabetes at 10 years (P < 0.001) independent of age, sex, BMI, family history of diabetes, and baseline fasting and 2-h glucose concentrations. CONCLUSIONS: The DI(O) provides a measure of beta-cell function adjusted for insulin sensitivity and is predictive of development of diabetes over 10 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The computed slopes (——) and 95% CIs for the slopes (– – –) for ln(ΔI0–30/ΔG0–30) versus ln(1/fasting insulin) are plotted for subjects with NGT (slope −0.87 [95% CI −1.13 to −0.61]) (A), IGM (−0.84 [−1.05 to −0.63]) (B), and diabetes (DM) (−0.76 [−1.16 to −0.35]) (C). D: The hyperbolic curves for NGT, IGM, and diabetes, assuming a slope of −1, are plotted for ΔI0–30/ΔG0–30 versus 1/fasting insulin.](https://figures.cochat.ai/paper-figures/d5959647a3dd4b95864a9b906f9e5ab4/oral-disposition-index-predicts-the-development-of-future-diabetes-above-and-figure-1.jpg)
![Figure 2 A: The DIO (ΔI0–30/ΔG0–30 × 1/fasting insulin) decreases from NGT to IGM to diabetes (DM) (median [interquartile range]). B: The logarithmic means for baseline ΔI0–30/ΔG0–30 and 1/fasting insulin values are plotted for subjects with NGT (▪ and □) and IGM (• and ○) as nonprogressors (▪ and •) and progressors (□ and ○) relative to the hyperbolic curves. Progressors had lower β-cell function at baseline. C: The number of subjects who developed diabetes over the 10-year follow-up period by quintiles of baseline DIO. D: ROC curves comparing ability of baseline ΔI0–30/ΔG0–30 (dotted line), 1/fasting insulin (dashed line), and DIO (solid line) to predict cumulative diabetes at 10 years.](https://figures.cochat.ai/paper-figures/739976092a5449f2822cbdd9e3aacbd4/oral-disposition-index-predicts-the-development-of-future-diabetes-above-and-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“whereas children and adults with a low disposition index are most likely to progress to type 2 diabetes (19,34–38).”
From Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism (2019) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784 · cited 1×
“Classification of glucose tolerance Using the 2003 American Diabetes Association criteria (18), subjects were categorized as having normal glucose tolerance (NGT) (fasting plasma glucose [FPG] 5.”
MethodKahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166 · cited 2×
“Abnormalities in -cell function are present in high-risk individuals long before they develop hyperglycemia (1).”
BackgroundSelf-citationCorrect Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Levy, J. C., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 2,013
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 1×
“sensitivity and insulin responses (2,3),”
Statistical Methods in Medical Research
Armitage, P., Berry, G., & Matthews, J. N. S. (2002) · Wiley eBooks · doi:10.1002/9780470773666 · Cited by 1,630
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · cited 4×
“intravenous tests (3) as well as between”
BackgroundInfluentialSelf-citationBuchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program
Florez, J. C., Jablonski, K. A., Bayley, N., Pollin, T. I., de Bakker, P. I. W., Shuldiner, A. R., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062418 · Cited by 839
Cited by
Items 401–500 of 569
Kadyada, S. P., Thapa, B. R., Kaushal, K., Walia, R., Rana, S., Dhaka, N., Lal, S. B., Prasad, R., Das, S., Thakur, R., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14288 · Cited by 6
Nutritional therapy in critically ill patients with diabetes
Doola, R., & Preiser, J. (2021) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000807 · Cited by 6
Schianca, G. P. C., Mella, R., Scaglia, E., Bigliocca, M., Colli, E., Fra, G. P., & Bartoli, E. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1166 · Cited by 7
Antepartum Oral Disposition Index as a Predictor of Glucose Intolerance Postpartum
Saisho, Y., Miyakoshi, K., Tanaka, M., Matsumoto, T., Minegishi, K., Yoshimura, Y., & Itoh, H. (2012) · Diabetes Care · doi:10.2337/dc11-2549 · Cited by 6
Rahman, M. M., Pathak, A., Schueler, K. L., Alsharif, H. A., Michl, A. N., Alexander, J., Kim, J., & Bhatnagar, S. (2023) · The FASEB Journal · doi:10.1096/fj.202300291rr · Cited by 5
Lipidomic profiling unveils sex differences in diabetes risk: Implications for precision medicine
Pina, A. F., Meneses, M. J., Carli, F., Patrício, B., Ribeiro, R. T., Patarrão, R. S., Gardete-Correia, L., Duarte, R., Boavida, J. M., Raposo, J. F., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70137 · Cited by 8
Sugimoto, H., Hironaka, K., Yamada, T., Otowa‐Suematsu, N., Hirota, Y., Otake, H., Hirata, K., Sakaguchi, K., Ogawa, W., & Kuroda, S. (2026) · eLife · doi:10.7554/elife.102860 · Cited by 5
“The disposition index (DI), which is the product of insulin sensitivity and insulin secretion, reflects and predicts glycemic disability beyond FBG ( Utzschneider et al., 2009 ).”
Ancu, O., Hauge-Evans, A. C., Draicchio, F., Neculescu, D.-E., Rogers, R., Burd, N. A., Pfeiffer, A. F. H., Weickert, M. O., Hurren, N. M., & Mackenzie, R. W. A. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag013 · Cited by 5
β-Cell function during a high-fat meal in young versus old adults: role of exercise
Malin, S. K., Frick, H., Wisseman, W. S., Edwards, E. S., Edwards, D. A., Emerson, S. R., & Kurti, S. P. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00047.2023 · Cited by 5
Hoffman, R. P., & Yu, C. Y. (2023) · Pediatric Research · doi:10.1038/s41390-023-02769-x · Cited by 5
Dorcely, B., de Bermont, J., Gujral, A., Reid, M., Vanegas, S. M., Popp, C. J., Verano, M., Jay, M. R., Schmidt, A. M., Bergman, M., et al. (2024) · Obesity Science & Practice · doi:10.1002/osp4.729 · Cited by 5
Tamaroff, J. G., Nguyen, S., Wilson, N. E., Stefanovski, D., Xiao, R., Scattergood, T. M., Capiola, C. J., Schur, G. M., Dunn, J., Dedio, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae545 · Cited by 6
The duodenal glucose load impacts the oral disposition index in healthy subjects
Marathe, C. S., Feinle‐Bisset, C., Pilichiewicz, A. N., Lange, K. M., Jones, K. L., Rayner, C. K., Kahn, S. E., & Horowitz, M. (2015) · Diabetic Medicine · doi:10.1111/dme.12802 · Cited by 5
Self-citationSchianca, G. P. C., Fra, G. P., Bigliocca, M., Mella, R., Rossi, L. C., & Bartoli, E. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12185 · Cited by 5
Sanctis, V. D., Daar, S., Soliman, A. T., Tzoulis, P., Yassin, M. A., & KATTAMIS, C. A. (2022) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v93i3.12825 · Cited by 7
Broadney, M. M., Belcher, B. R., Ghane, N., Sheni, R., Jayson, M. J., Trenschel, R. W., Collins, S. M., Brychta, R. J., Davis, E. K., Brady, S. M., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13430 · Cited by 7
Fuller, K. N. Z., Bohne, E. M., Mey, J. T., Blackburn, B. K., Miranda, V. R., Varady, K. A., Danielson, K. K., & Haus, J. M. (2023) · Metabolism Open · doi:10.1016/j.metop.2023.100264 · Cited by 6
“Finally, the oral disposition index was calculated as Δ Insulin 0-30mins divided by Δ Glucose 0-30mins multiplied by 1/fasting insulin [27].”
MethodSato, Y., Oka, R., Nakasone, Y., Katakura, M., Yamauchi, K., & Aizawa, T. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0122 · Cited by 5
Mayasari, N., & Wirawanni, Y. (2014) · Journal of Nutrition College · doi:10.14710/jnc.v3i4.6829 · Cited by 5
Trajectories of oral glucose tolerance testing in cystic fibrosis
Patel, M., McCracken, C. M., Daley, T. C., Stecenko, A. A., & Linnemann, R. W. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.25207 · Cited by 6
“In non‐CF individuals, baseline DI has been shown to be significantly lower in individuals who later developed Type 2 DM compared to those who remained without DM.26 DI has been shown to be significantly lower in CF patients with normal OGTTs compared to non‐CF controls and is further decreased in CF patients with CFR…”
BackgroundRoy, A., Kamalanathan, S., Sahoo, J., Kar, S. S., Naik, D., Narayanan, N., Merugu, C., & Patel, D. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108846 · Cited by 5
Jiang, Y., Cui, S., Zhang, R., Zhao, X., Yao, L., Ouyang, R., Chen, W., Zhou, R., Zhao, X., Tang, Z., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01107-w · Cited by 5
Deischinger, C., Bastian, M., Leitner, K., Bancher‐Todesca, D., Kiss, H., Baumgartner-Parzer, S. M., Kautzky‐Willer, A., & Harreiter, J. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02151-7 · Cited by 5
“Finally, the oral Disposition Index is the product of the IGI and 1/fasting insulin (ΔI 0–30 /ΔG 0–30 × 1/fasting insulin) [29].”
BackgroundPathogenesis of Insulin Resistance and Glucose Intolerance in Childhood Obesity
Weiss, R., & Hagman, E. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_23 · Cited by 6
Bloomgarden, Z. T. (2011) · Diabetes Care · doi:10.2337/dc11-0591 · Cited by 5
“In impaired glucose tolerance (IGT)/impaired fasting glucose (IFG) and, to a considerably greater extent, in diabetes, the curve is shifted downward, with lower disposition index (29).”
BackgroundYamauchi, K., & Aizawa, T. (2013) · Diabetologia · doi:10.1007/s00125-013-3046-2 · Cited by 5
Frailty Is Associated With Insulin Resistance in Chronic Human Immunodeficiency Virus Infection
Chow, D. C., Bernas, M., Gangcuangco, L. M. A., Huynh, J., Kohorn, L. B., Kallianpur, K. J., Souza, S. A., Shiramizu, B. T., Ndhlovu, L. C., & Shikuma, C. M. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1017 · Cited by 5
Won, K. C. (2018) · Cited by 5
Kim, J. Y., Lee, J., Kim, S. G., & Kim, N. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0601 · Cited by 5
Wang, J., Liu, L., Liu, H., Qian, Y., Zhang, S., Zheng, S., Jiang, H., Zhou, Y., Cheng, X., Fu, Q., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102327 · Cited by 5
Hoffman, R. P., Copenhaver, M. M., Zhou, D., & Yu, C. Y. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0619 · Cited by 4
Kinin B1 receptor deficiency protects mice fed by cafeteria diet from abnormal glucose homeostasis
Correia, P. E., Gomes, C. B., Bandeira, V. A., Marten, T., da Natividade, G. R., Merello, P. N., Tozawa, E., Cerski, C. T. S., Budu, A., Araújo, R. C., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267845 · Cited by 4
No Indices of Increased Type 2 Diabetes Risk in Individuals with Reactive Postprandial Hypoglycemia
Volčanšek, Š., Perc, U. R., Lunder, M., & Barlovič, D. P. (2022) · Metabolites · doi:10.3390/metabo12121232 · Cited by 4
“The disposition index correlates strongly with glucose tolerance, such that individuals with the lowest disposition index are at increased risk of type 2 diabetes [18,19].”
BackgroundMethodPathogenesis of Insulin Resistance and Glucose Intolerance in Childhood Obesity
Weiss, R., Cali, A. M. G., & Caprio, S. (2010) · Springer eBooks · doi:10.1007/978-1-60327-874-4_13 · Cited by 5
Yang, H. K., Ha, H., Rhee, M., Lee, J., Park, Y., Kwon, H., Yim, H., Kang, M., Lee, W., Son, H., et al. (2016) · Medicine · doi:10.1097/md.0000000000003053 · Cited by 4
“The early phase insulin secretion was assessed, using the insulinogenic index which was calculated by (30-min insulin [mU/mL]–0-min insulin)/(30-min glucose [mg/dL]–0-min glucose).(22) The firstand second-phase insulin secretion were evaluated using the following equations: first-phase insulin release 1⁄4 1283 þ 1.”
MethodUncovering Factors Related to Pancreatic Beta-Cell Function
Curran, A. M., Ryan, M. F., Drummond, E. M., Gibney, E. R., Gibney, M. J., Roche, H. M., & Brennan, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161350 · Cited by 5
“DInsulin30=DGlucose30 ð Þ 1 fastingInsulin [22].”
Kim, J. Y., Tfayli, H. M., Bacha, F. F., Lee, S., Gebara, N. Y., & Arslanian, S. A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154346 · Cited by 4
“, disposition index [DI]) is the strongest metabolic predictor of future type 2 diabetes in adults [11].”
BackgroundPrediction of diabetes mellitus induced by steroid overtreatment in adrenal insufficiency
Guarnotta, V., Tomasello, L., & Giordano, C. S. D. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-04904-w · Cited by 5
Sanctis, V. D., Daar, S., Soliman, A. T., Tzoulis, P., Karimi, M., & KATTAMIS, C. A. (2022) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v93i3.12643 · Cited by 4
Narayanan, N., Sahoo, J., Kamalanathan, S., Sagili, H., Bobby, Z., Naik, D., Roy, A., & Merugu, C. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_7_23 · Cited by 4
“[30] We assessed the oDI, which was significantly low in women with GDM compared with NGT women.”
MethodAkinlade, K. S. (2014) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2014/11054 · Cited by 4
“These include the euglycaemic clamp [13], homeostasis model assessment-estimated insulin resistance (HOMA-IR) [14], quantitative insulin sensitivity check index (QUICKI) [15], Matsuda index of insulin sensitivity [16], oral disposition index (DIO) [17], insulinogenic index of β-cell function [18] and insulin secretion…”
MethodResultInfluentialDuong, J. K., de Winter, W., Choy, S., Plock, N., Naik, H., Krauwinkel, W. J. J., Visser, S. A. G., Verhamme, K. M. C., Sturkenboom, M., Stricker, B. H. C., et al. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13144 · Cited by 5
Fu, Q., Sun, M., Wang, Z., He, W., Duan, Y., & Yang, T. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0325 · Cited by 4
Shestakova, E. A., Sklyanik, I. A., Сергеевна, П. А., & Shestakova, M. V. (2018) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn1027 · Cited by 4
Categorization of β-cell capacity in patients with obesity via OGTT using K-means clustering
Li, L., Song, Q., & Yang, X. (2020) · Endocrine Connections · doi:10.1530/ec-19-0476 · Cited by 4
Roberts, K. A., Draijer, R., Hopkins, N. D., de Graaf, Y., Holder, S. M., Carter, S. E., Thijssen, D. H. J., & Low, D. A. (2021) · Physiological Reports · doi:10.14814/phy2.14720 · Cited by 4
Monroy, G., Fernández, C., Caballé, T., Altimira, L., & Corcoy, R. (2022) · Diabetic Medicine · doi:10.1111/dme.14954 · Cited by 5
Pei, L., Lai, F., Chen, W., Zeng, R., Chen, N., Li, Y., Xiao, H., & Cao, X. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110892 · Cited by 4
Effects of Roux-en-Y Gastric Bypass on β-Cell Function
Weiss, R. (2014) · Diabetes · doi:10.2337/db13-1897 · Cited by 5
Sanctis, V. D., Daar, S., Soliman, A. T., Tzoulis, P., Yassin, M. A., & KATTAMIS, C. A. (2023) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v94i6.15001 · Cited by 3
Ren, S., Wu, D., & Li, P. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117753 · Cited by 3
Li, M. Y., Sharma, K., Chon, J.-E., Yehia, N. A., Retnakaran, R. R., Harris, S. B., & Hanley, A. J. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113163 · Cited by 3
Mengen, E., & Uçaktürk, S. A. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0016 · Cited by 3
Ziv, O., Cahn, A., Jansen, T., Istomin, V., Kedem, E., Olshtain‐Pops, K., Israel, S., Oster, Y., Orenbuch‐Harroch, E., Korem, M., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae167 · Cited by 4
Sabatini, S., Nolan, J. J., O’Donoghue, G., Kennedy, A., Petrie, J. R., Walker, M., O’Gorman, D. J., & Gastaldelli, A. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155910 · Cited by 7
“A β -cell reduction was also confirmed when measured during OGTT by the disposition index, either using 120 minutes [4,5] or 30 minutes [6] glucose and insulin profiles.”
Sawicki, C. M., Ren, Y., Kanaya, A. M., Kandula, N. R., Gadgil, M. D., Liang, L., Haslam, D. E., & Bhupathiraju, S. N. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.06.007 · Cited by 3
Minato-Inokawa, S., Honda, M., Tsuboi-Kaji, A., Takeuchi, M., Kitaoka, K., Kurata, M., Wu, B., Kazumi, T., & Fukuo, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-69181-1 · Cited by 3
“In conclusion, an inverse association of AT-IR with DI, an early marker of inadequate β-cell compensation and a reliable predictor of type 2 diabetes 3 , in young Japanese female university students may suggest that lipo-toxicity to pancreatic β-cells 5 may be associated with impaired β cell…”
BackgroundCiresi, A., Amato, M. C., Bianco, J., & Giordano, C. S. D. S. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0423 · Cited by 3
“DIo was calculated at the time 0′ and 30′ during OGTT as described, using the following formula, where insulin levels are expressed in IU/mL and glucose levels in mmol/L: DIo = [Δ insulin 0′–30′/Δ glucose 0′–30′] × 1/fasting insulin [15].”
MethodREDONDO, M. J., WARNOCK, M. V., Libman, I. M., Bocchino, L. E., Cuthbertson, D. D., Geyer, S. M., Pugliese, A., Steck, A. K., Evans‐Molina, C., Becker, D. J., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0531 · Cited by 3
Wentzel, A., Karera, M. G. D., Patterson, A. C., Waldman, Z. C., Schenk, B. R., Mabundo, L. S., DuBose, C. W., Horlyck-Romanovsky, M., & Sumner, A. E. (2022) · Scientific Reports · doi:10.1038/s41598-022-19917-8 · Cited by 3
Sanctis, V. D., Daar, S., Soliman, A. T., Tzoulis, P., Yassin, M. A., & KATTAMIS, C. A. (2023) · PubMed Central · doi:10.23750/abm.v94i6.14909 · Cited by 5
Rodrigues, S., Bortolotto, L. A., Beyl, R. A., & Singh, P. (2023) · Frontiers in Sleep · doi:10.3389/frsle.2023.1295301 · Cited by 3
“…the early insulin response during the OGTT, 1 insulin/ glucose from 0 to 30 min) (Goedecke et al., 2009), disposition index (Beta-cell function estimate, Matsuda Index × insulinogenic index) (Utzschneider et al., 2009), and HOMA-IR [(fasting insulin × fasting glucose)/22.5] (Matthews et al., 1985).”
InfluentialPancreatic β‐cell Function is Higher in Morning Versus Intermediate Chronotypes With Obesity
Malin, S. K., Remchak, M. E., Heiston, E. M., Fabris, C., & Shah, A. M. (2025) · Obesity Science & Practice · doi:10.1002/osp4.70064 · Cited by 3
Pangestu, Y. M., Antolis, A., Pateda, V., Kristellina, T., & Warouw, S. M. S. (2016) · Sari Pediatri · doi:10.14238/sp15.3.2013.161-6 · Cited by 3
Osei, K., & Gaillard, T. R. (2018) · Journal of the National Medical Association · doi:10.1016/j.jnma.2018.06.004 · Cited by 3
Yu, Y., Pan, F., Cui, W., Tang, W., & Hu, Y. (2020) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13861 · Cited by 3
Boyko, E. J. (2010) · Diabetes Care · doi:10.2337/dc10-0196 · Cited by 3
Self-citationArreola, E. V., Hanson, R. L., Bogardus, C., & Knowler, W. C. (2021) · doi:10.2337/figshare.16811152 · Cited by 3
Rodeles, L. M., Vicco, M. H., Siano, Á., Fuchs, L. A., Peverengo, L. M., Puch, S. I. S., Cymeryng, C. B., Marcipar, I. S., & Arias, P. (2021) · Pathogens · doi:10.3390/pathogens10030378 · Cited by 2
Beta cell function in the early stages of type 1 diabetes: still a long way ahead of us
Galderisi, A. (2023) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2023.126360 · Cited by 2
D’Alessio, D. A., & Kahn, S. E. (2025) · Diabetes · doi:10.2337/dbi24-0049 · Cited by 2
Self-citationHuhtala, M. S., Rönnemaa, T., Tertti, K., Niinikoski, H., & Paavilainen, E. (2025) · Metabolomics · doi:10.1007/s11306-025-02281-9 · Cited by 2
“Finally, β-cell function in relation to insu - lin resistance was estimated by oral disposition index (oDI Ins and oDI CP ) defined as 1/Insulin 0 × ΔInsulin 0–30 /ΔGlucose 0–30 and 1/C-peptide 0 × ΔC-peptide 0–30 /ΔGlucose 0–30 , respectively (Sjaarda et al., 2012; Utzschneider et al., 2009).”
Miyamoto, M., Miya, A., Nakamura, A., Takahashi, Y., Yamauchi, Y., Yanagiya, S., Takase, T., Ono, M., Takahashi, K., Okada, K., et al. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70245 · Cited by 2
HUEFNER, E. A., Ntabadde, K., Smith, G. G., Bigirimana, S. P., DuBose, C. W., Sherman, A., & Sumner, A. E. (2026) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005504 · Cited by 3
Sanctis, V. D., Soliman, A. T., Daar, S., Tzoulis, P., & Kattamis, C. (2025) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v96i2.16957 · Cited by 2
Assessment of Islet Alpha- and Beta-Cell Function
Madsbad, S., & Holst, J. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_2 · Cited by 4
Leutner, M., Matzhold, C., Bellach, L., Deischinger, C., Stefan Thurner, A., Klimek, P., & Kautzky‐Willer, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-70075-1 · Cited by 2
Kishimoto, I., & Ohashi, A. (2022) · Metabolites · doi:10.3390/metabo12111022 · Cited by 2
Sanctis, V. D., Daar, S., Soliman, A. T., Tzoulis, P., Maio, S. D., & KATTAMIS, C. A. (2023) · PubMed Central · doi:10.23750/abm.v94i4.14631 · Cited by 5
Sanctis, V. D., Soliman, A. T., Daar, S., Tzoulis, P., & KATTAMIS, C. A. (2024) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2024.005 · Cited by 4
Shen, T., Zheng, Q., Zhong, L., Zeng, X., Yuan, X., Mo, F., Zhu, S., Yang, W., & Chen, Q. (2024) · BMC Public Health · doi:10.1186/s12889-023-17471-0 · Cited by 2
“On this basis, the disposition index (DI), which combines insulin sensitivity and islet secretion function, can be used to evaluate β -cells under compensation because it corrects insulin resistance [17].”
MethodGAD65Abs Are Not Associated With Beta-Cell Dysfunction in Patients With T2D in the GRADE Study
Hampe, C. S., Shojaie, A., Brooks‐Worrell, B., Moghadam, S. D., Utzschneider, K. M., Kahn, S. E., Larkin, M., Johnson, M. L., Younes, N., Rasouli, N., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad179 · Cited by 3
“…to the iAUC of glucose from 0-120 minutes (iAUC-CG, nmol/mg) adjusted for insulin sensitivity, with iAUC calculated using the trap-ezoidal rule [22] and ratio of the increment of C-peptide to that of glucose over the first 30 minutes (C-peptide index: [ Δ C-peptide (0-30 min)/ Δ glucose (0-30…”
MethodSelf-citationPancreatic Beta Cell Function in Infants Varies by Maternal Weight
Staimez, L. R., Dutta, A., Beyh, Y. S., Gupta, R., Noule, H. K., Vyakaranam, S., Deepa, K. P., Stein, A. D., Narayan, K. M. V., Prabhakaran, D., et al. (2024) · Metabolites · doi:10.3390/metabo14040208 · Cited by 2
“Second, our selected measures of beta cell function, including the oral disposition index, are rigorous and predictive of future diabetes in adolescents and adults [30].”
BackgroundHani, N. S., Vajravelu, M. E., Meijer, J. L., McCaffery, H., Sturza, J. S., Dhadphale, E., & Lee, J. M. (2024) · Pediatric Diabetes · doi:10.1155/2024/2136173 · Cited by 2
Kim, M. K., Kwon, H., Baek, K., & Song, K. (2024) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2024.10.004 · Cited by 2
Yuan, F., Fang, D., Xu, H., Nie, Y., Cai, W., & Gu, T. (2024) · Diabetes & Metabolism · doi:10.1016/j.diabet.2024.101588 · Cited by 3
Baltogianni, M. S., Dermitzaki, N., Giapros, V. I., Balomenou, F., Kosmeri, C., Ladomenou, F., Kantza, E., & Serbis, A. (2025) · Children · doi:10.3390/children12010050 · Cited by 3
Minato-Inokawa, S., Honda, M., Tsuboi-Kaji, A., Takeuchi, M., Kitaoka, K., Kurata, M., Wu, B., Kazumi, T., & Fukuo, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-05949-3 · Cited by 2
“In addition, low leg fat was associated with pancreatic β-cell dysfunction (a low ODI, a predictor of future development of diabetes above and beyond fasting and 2-h glucose levels) 22 , high glucose excursion (AUCg), and a high prevalence of HbA1c-defined prediabetes.”
L’hyperglycémie provoquée par voie orale (HGPO) revisitée
Scheen, A. J., & Luyckx, F. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70163-2 · Cited by 3
L’hyperglycémie provoquée par voie orale (HGPO) revisitée
Scheen, A. J., & Luyckx, F. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70124-3 · Cited by 7
Takai, T., Sakura, H., Uchigata, Y., & Iwamoto, Y. (2012) · Diabetology International · doi:10.1007/s13340-011-0064-5 · Cited by 2
“Previous studies have shown that DIs may be good predictors for the development of diabetes in non-diabetic subjects [6, 7].”
BackgroundPraveen, E. P., Chouhan, S. S., Sahoo, J., Goel, S. K., Dwivedi, S. N., Khurana, M. L., Kulshreshtha, B., & Ammini, A. C. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0379 · Cited by 3
Alexandraki, K., Boutzios, G., Antonopoulou, I., Papaioannou, T., Bartsioka, L. I., Moschouris, P., Karapanagioti, A., Mavroeidi, V., Makrilakis, K., Duntas, L. H., et al. (2020) · Archives of the Balkan Medical Union · doi:10.31688/abmu.2020.55.2.02 · Cited by 2
Lan‐Pidhainy, X. (2012) · TSpace (University of Toronto) · Cited by 2
Increased Pre- and Post-Meal Free Fatty Acid Levels in Black, Obese Adolescents
Cazeau, R.-M., Rauch, L., Huang, H., Bauer, J. A., & Hoffman, R. P. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0122 · Cited by 1
Schmidt, K. A., Mokhtari, P., Holzhausen, E. A., Alderete, T. L., Allayee, H., Nayak, K. S., SINATRA, F. R., Pickering, T. A., Mack, W. J., Kohli, R., et al. (2023) · Nutrients · doi:10.3390/nu15153338 · Cited by 3
“Oral-DI is a significant biomarker of disease risk and has been indicated to be more important in predicting the future development of type 2 diabetes as compared to fasting and 2-h glucose levels [31].”
Goedecke, J. H., Kufe, C. N., Masemola, M., Lichaba, M., Seipone, I. D., Mendham, A. E., Gibson, H., Hawley, J. M., Selva, D. M., Magodoro, I. M., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf256 · Cited by 2
Kunzi, H., Nsanya, M. K., Kweka, B. V., MALINDISA, E. K., Ngissa, N. S., Kavishe, B. B., Jeremiah, K., Olsen, M. F., Krogh‐Madsen, R., Filteau, S., et al. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003816 · Cited by 1
“We computed homeostatic model assessment-β (HOMA-β ), insulinogenic index (IGI) and oral disposition index (ODI) as markers of β -cell function, and HOMA-insulin resistance (HOMA-IR) and Matsuda index as markers of insulin resistance [40,41] (S1 Table).”
Fu, Q., Dai, H., Wang, J., Liu, L., Silva, L. F., Jiang, H., Yu, Q., Fu, Z., Peng, R., Xia, Z., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf372 · Cited by 1
Riley, T. M., Weschenfelder, C., Ravussin, É., Rood, J. C., Greenway, F. L., Taff, S., Hickner, R. C., Cao, H., Sutin, A. R., Todd, G., et al. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.108167 · Cited by 1
Metadata
- Authors
- Utzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E.
- Affiliations
- University of Washington (US)
- University of Maryland, Baltimore (US)
- VA Puget Sound Health Care System (US)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-02-01
- Volume
- 32
- Issue
- 2
- Pages
- 335-341
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2628704
- OpenAlex
- W2121328463
- Cited by
- 572
- References
- 27
- Citations by year
- 2026: 24 · 2025: 30 · 2024: 39 · 2023: 41 · 2022: 40 · 2021: 44 · 2020: 41 · 2019: 27 · 2018: 32 · 2017: 32 · 2016: 42 · 2015: 26 · 2014: 35 · 2013: 29 · 2012: 35
- FWCI
- 13.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (P30 DK, HL‐49293, DK-31170)
- National Heart, Lung, and Blood Institute (R01HL049293)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-35816, P30-DK 17047, K24DK002654, DK 02654, R01DK031170, P30DK035816, P30DK017047)
- National Center for Research Resources (RR00037, M01RR000037)
- NIH Clinical Center (RR-00037)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD042828)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- oral disposition index, diabetes prediction, beta-cell function, insulin sensitivity, hyperbolic relationship, oral glucose tolerance test, impaired fasting glucose, impaired glucose tolerance, HOMA-S, fasting insulin
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Fasting, Feedback, Follow-Up Studies, Glucose Tolerance Test, Humans, Hyperglycemia, Insulin, Insulin Resistance, Predictive Value of Tests, Regression Analysis, Time Factors, Reproducibility of Results, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.